Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03637413
Other study ID # REB18-0195
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 22, 2019
Est. completion date December 31, 2022

Study information

Verified date November 2022
Source University of Calgary
Contact Belal Alshaikh, MD, MSc
Phone 403-955-2320
Email belal.alshaikh@ahs.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Research question: Does feeding hindmilk improve weight gain in very preterm infants with poor growth velocity? Hypothesis: In very preterm infants (born less than 32 weeks gestation) with poor postnatal growth velocity (<15 g/kg/day), feeding hindmilk would improve average weight gain by at least 4 g/kg per day. Study design: This will be a prospective cohort study in very preterm infants admitted to the Neonatal Intensive Care Unit (NICU) at Foothills Medical Centre


Description:

Extra-uterine growth restriction (EUGR) is one of the most common findings among very preterm infants at discharge from neonatal intensive care units. EUGR is associated with major morbidities such as bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) and impaired neurodevelopment. EUGR is caused by slow postnatal growth and largely results from energy and protein deficits. These deficits occur despite the current fortifications of human milk. Hindmilk, the milk at the end of a breast pumping session, has higher fat and energy content compared to the composite milk. Feeding hindmilk can be a natural and innovative way to provide additional calories for very preterm infant. Hindmilk is rich in some fatty acids that are currently under investigation to prevent BPD and ROP and improve neurodevelopment. The aim of this study is to assess growth benefits of feeding hindmilk and to explore whether it can improve fatty acids profile in very preterm infants. Dietitians (RD) and Lactation Consultant (LC) will screen and identify eligible mother-infant pairs. Once mother's consent obtained, LC will hand out the "hindmilk information sheet" and teach the mother how to separate her milk. A sample (10 ml) of composite pumped fresh milk will be collected and placed in the fridge. These samples will be sent for analysis within 24 hours of collection to minimize any changes to contents. Samples for Erythrocyte membrane fatty acid (FA) profile will be collected on dried blood spot (30-100 µL). These samples will be collected within 72 hours of the consent. It will be coordinated with blood tests ordered by the clinical team within that period. Dried blood spots are stable in room temperature for 28 days however we will store them in the -80̊ C freezer within 72 hours of collection. Another milk sample, hindmilk this time, will be sent for testing within 24-48 hour of starting hindmilk. This is to ensure that assessment of milk contents is performed in the same mother's lactation stage. The second dried blood spot will be drawn after 2-4 weeks of starting hindmilk. The 2-4 weeks period is to allow timing with other blood work-ups. In General, blood glucose is done every 2-3 days in babies with poor growth and growth laboratory testing is normally done every 2-3 weeks. Data on fluid volumes, feeds, macronutrients intakes and any change in nutrition plan will be collected from electronic dietitian's notes. Dietitians will ensure proper and detailed documentation of nutritional information. Average weight gain (in gram/kg per day) is calculated as mentioned before. Average weight gain will be compared initially between the week before and the week after starting hindmilk. The day that hindmilk started will be used to identify the start point however it will not be used in either the pre- or the post-hindmilk calculation. Clinical team will be encouraged to not order other changes to the nutrition plan for the first week after starting hindmilk. Daily weight, weekly length and head circumference will be collected from the electronic charts. Furthermore, weight, length and head circumference at completed gestational week will be used to calculate Z scores using Fenton Z scores calculator. Data on maternal and neonatal characteristics will be collected from their electronic and physical charts. Composite milk, foremilk and hindmilk volumes will be collected from the collection sheet that has been already used in our NICU.


Recruitment information / eligibility

Status Recruiting
Enrollment 34
Est. completion date December 31, 2022
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 2 Weeks and older
Eligibility Inclusion Criteria: - Very preterm infant ( <32 weeks at birth) - On full enteral feeds for more than 2 weeks (full feed is defined at the time of reaching 120 ml/kg/day with no parenteral nutrition used) - Poor weight gain (<15 g/kg per day) despite optimization of energy and protein intakes by RDs (calories intake: 125-135 Kcal/kg per day and protein: 4-4.5 g/kg per day) - Mothers have enough milk supply (>150% of infant's daily needs) Exclusion Criteria - Congenital anomalies - Small for gestational age infants (< 10th percentile) at birth

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Hindmilk
Mother will be taught to separate her milk and infant will receive only hindmilk for feeds

Locations

Country Name City State
Canada Foothills Medical Centre Calgary Alberta

Sponsors (1)

Lead Sponsor Collaborator
Belal Alshaikh

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average Weight Gain Difference in weight gain the week before hindmilk and the week after 2 weeks
Secondary Effect of feeding hindmilk on anthropometrics Compared to published rates in NICUs At 36 weeks post menstrual age and/or discharge (up to 13 weeks)
Secondary Effect of feeding hindmilk on body mass index Compared to published rates in NICUs At 36 weeks post menstrual age and/or discharge (up to 13 weeks)
Secondary Incidence of extra uterine growth restriction Defined as wight less than 10th percentile. Compared to published rates in NICUs At 36 weeks post menstrual age and/or discharge (up to 13 weeks)
Secondary Incidence of bronchopulmonary dysplasia and retinopathy of prematurity BPD will be defined according to Child Health and Human Development as the requirement for positive pressure support (CPAP or high flow nasal cannula = 1 liter per minute (LPM)), or oxygen dependency at 36 corrected gestational age. ROP will be defined according to the international classification1 or requiring treatment. Compared to published rates in NICUs At 36 weeks post menstrual age and/or discharge (up to 13 weeks)
Secondary Correlation between human milk content (fat, protein and energy) and weight gain Linear regression analysis will be used to correct for any confounding factors Within 4 weeks of enrollment
Secondary Effect of hindmilk on erythrocyte membranes fatty acids profile. Comparison between sample taken at 24 hours and sample at week 2-4 after hindmilk Within 4 weeks of enrollment
Secondary Changes in mother's milk volumes after feeding hindmilk. Monitor the milk output of mothers throughout the study Until 36 weeks post menstrual age and/or discharge (up to 13 weeks)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03249896 - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes N/A
Recruiting NCT04043520 - Bioenergetic Effects of Aging and Menopause (BEAM) Phase 4
Completed NCT05508750 - Growth and Safety Clinical Trial on a New Infant Formula N/A
Not yet recruiting NCT03225456 - Oxytocin and Eating Phase 2
Completed NCT02227043 - Study Of Weight Development Over Time N/A
Not yet recruiting NCT01916603 - Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development N/A
Completed NCT01958307 - Healthy Living in Pregnancy N/A
Completed NCT01693666 - Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study) N/A
Completed NCT01461824 - Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects Phase 3
Terminated NCT00759993 - Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units. Phase 2
Completed NCT00634530 - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy N/A
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00122213 - A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women Phase 2
Completed NCT00306449 - Prevention of Weight Gain in Young Adults N/A
Completed NCT03996551 - ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study N/A
Recruiting NCT03675464 - Study of Human Adipose Tissue (LOSHAT)
Completed NCT04282655 - Effect of Milk Warming on the Very Low Birth Weight Infant N/A
Recruiting NCT05992688 - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time) N/A
Completed NCT04069351 - Body Composition Changes During Overfeeding Plus Resistance Training N/A
Completed NCT00687115 - Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting Phase 2